kidney disease
RenalytixAI, Wake Forest, Atrium Health Partner on Kidney Health Initiative
RenalytixAI will offer its KidneyIntelX platform through Atrium Health's electronic health record system at 37 hospitals across the Carolinas and Georgia.
Renalytix AI Lands US Government Contract for Kidney Disease Test
The firm said that the contract covers early-stage kidney disease testing that can be provided by more than 140 US government departments, agencies, and affiliates.
Following the launch of its urine-based Qsant assay later this year, the firm plans to develop updated versions of it with new biomarkers for different disease indications.
Bio-Techne expects the acquisition will provide it with a basis to build out its IVD presence, given Asuragen's diagnostic tests and regulatory expertise.
NephroSant Raises $16M in Series A Funding Round
The startup will use the funds to support R&D and to launch its Qsant urine test to help determine if a patient's body is rejecting a kidney transplant.